Climb Bio Stock Analysis
| CLYM Stock | 2.10 0.17 7.49% |
Climb Bio is overvalued with Real Value of 2.02 and Hype Value of 1.46. The main objective of Climb Bio stock analysis is to determine its intrinsic value, which is an estimate of what Climb Bio is worth, separate from its market price. There are two main types of Climb Bio's stock analysis: fundamental analysis and technical analysis.
The Climb Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Climb Bio is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Climb Stock trading window is adjusted to America/New York timezone.
Climb |
Climb Stock Analysis Notes
The company had not issued any dividends in recent years. For more info on Climb Bio please contact BAO BCh at 866 857 2596 or go to https://eliemtx.com.Climb Bio Investment Alerts
| Climb Bio generated a negative expected return over the last 90 days | |
| Climb Bio has high historical volatility and very poor performance | |
| Climb Bio has a very high chance of going through financial distress in the upcoming years | |
| Climb Bio was previously known as Eliem Therapeutics and was traded on NASDAQ Exchange under the symbol ELYM. | |
| Net Loss for the year was (35.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from seekingalpha.com: Climb Bio set to join Nasdaq Biotech Index |
Technical Drivers
As of the 30th of December, Climb Bio shows the Risk Adjusted Performance of (0.21), mean deviation of 3.65, and Standard Deviation of 4.81. Climb Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Climb Bio coefficient of variation and maximum drawdown to decide if Climb Bio is priced correctly, providing market reflects its regular price of 2.1 per share. Please also double-check Climb Bio jensen alpha, which is currently at (1.35) to validate the company can sustain itself at a future point.Climb Bio Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Climb Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Climb Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Climb Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Climb Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Climb Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Climb Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Emily Pimblett over a week ago Acquisition by Emily Pimblett of 5000 shares of Climb Bio subject to Rule 16b-3 | ||
Williams Douglas E over a month ago Insider Trading |
Climb Bio Predictive Daily Indicators
Climb Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Climb Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Climb Bio Forecast Models
Climb Bio's time-series forecasting models are one of many Climb Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Climb Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Climb Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Climb Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Climb shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Climb Bio. By using and applying Climb Stock analysis, traders can create a robust methodology for identifying Climb entry and exit points for their positions.
Climb Bio is entity of United States. It is traded as Stock on NASDAQ exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Climb Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.